Cardiff Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.2	17.47	51.47	21.66	16.35	11.94
Short-Term Investments	25.32	40.83	40.28	53.17	88.92	128.88
Cash & Short-Term Investments	34.52	58.3	91.75	74.82	105.27	140.82
Cash Growth	-51.35%	-36.45%	22.62%	-28.92%	-25.25%	7.51%
Accounts Receivable	0.19	0.18	0.77	0.29	0.77	0.54
Other Receivables	-	0.3	0.4	0.6	-	-
Receivables	0.19	0.48	1.17	0.89	0.77	0.54
Prepaid Expenses	0.88	1.34	2.14	1.7	5.25	4.77
Total Current Assets	35.59	60.13	95.05	77.41	111.28	146.13
Property, Plant & Equipment	0.81	1.21	2.07	2.95	3.52	3.18
Other Long-Term Assets	0.93	0.55	0.07	1.28	1.39	0.24
Total Assets	37.33	61.88	97.19	81.64	116.19	149.54
Accounts Payable	3.99	8.09	4.82	1.97	1.96	1.44
Accrued Expenses	6.35	6.83	7.9	7.78	5.18	4.11
Current Portion of Leases	0.46	0.73	0.71	0.69	0.68	0.55
Other Current Liabilities	-	0.74	-	-	-	0.46
Total Current Liabilities	10.8	16.39	13.43	10.44	7.81	6.56
Long-Term Leases	-	0.1	0.81	1.46	2.04	2.57
Total Liabilities	10.8	16.5	14.24	11.9	9.85	9.13
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	478.19	475.36	467.09	409.34	404.83	400.5
Retained Earnings	-451.61	-430.03	-384.18	-339.54	-298.1	-259.81
Comprehensive Income & Other	-0.06	0.05	0.03	-0.07	-0.4	-0.28
Total Common Equity	26.53	45.39	82.95	69.74	106.34	140.42
Shareholders' Equity	26.53	45.39	82.95	69.74	106.34	140.42
Total Liabilities & Equity	37.33	61.88	97.19	81.64	116.19	149.54
Total Debt	0.46	0.83	1.52	2.15	2.72	3.12
Net Cash (Debt)	34.06	57.47	90.22	72.67	102.55	137.7
Net Cash Growth	-51.18%	-36.30%	24.15%	-29.13%	-25.53%	5.83%
Net Cash Per Share	0.50	0.86	1.89	1.63	2.35	3.53
Filing Date Shares Outstanding	77.8	68.36	66.52	44.68	44.68	43.31
Total Common Shares Outstanding	68.5	68.31	66.52	44.68	44.68	41.96
Working Capital	24.8	43.73	81.63	66.97	103.48	139.57
Book Value Per Share	0.39	0.66	1.25	1.56	2.38	3.35
Tangible Book Value	26.53	45.39	82.95	69.74	106.34	140.42
Tangible Book Value Per Share	0.39	0.66	1.25	1.56	2.38	3.35
Machinery	2.18	2.48	2.47	2.42	2.12	1.86
Leasehold Improvements	2.57	2.57	2.57	2.57	2.56	1.96

SEC Filings: 10-K · 10-Q